Next-generation submerged technology addresses large new market to upgrade larger centralized municipal wastewater treatment plants; Expected to be commercially available by Q2 of 2018
Wins First SUBRE Contract
Melbourne, Oct 9, 2017 AEST (ABN Newswire) - Fluence Corporation Limited (ASX:FLC) (EMFGF:OTCMKTS) ("Fluence" or the "Company"), a global leader in water and wastewater treatment solutions, today announced that it has been awarded its first SUBRE contract to upgrade a centralized wastewater treatment plant. The customer, Mayanot Ha-Amakim (MAH), a water utility in Israel, has selected Fluence to upgrade its Mayan Zvi ("MZ") wastewater treatment plant. SUBRE enables compliance with tighter nitrogen discharge rules without using hazardous chemicals and also increases plant capacity. Fluence estimates that several thousand plants globally currently require upgrades, a new market for the company. Full upgrades are estimated to cost an average of US$4-5 million per plant. SUBRE marks yet another key milestone in the planned development and commercialization of the MABR technology. It leverages all the key benefits of MABR now into a new market segment allowing upgrades of existing wastewater treatment plants of unlimited capacity globally.
The MZ wastewater treatment plant was constructed in 2007 and has 2 treatment lines in parallel designed to treat a daily volume of 6000 cubic meters (m3). The upgrade project aims to deploy the SUBRE technology to increase treatment capacity at the MZ plant by 15-20% to a daily volume of 6,900-7,200 m3. The upgrade is expected to reduce the treatment cost per unit volume and improve the MZ plant's effluent quality in compliance with local reuse requirements. The total project value is estimated to be US $450,000 and funding will be supported by the Israel Water Authority.
Yehuda Sisso and Uri Shmuel, CEO and Chairman of MHA, respectively, commented, "We are proud to lead the industry as the first utility to adopt Fluence's new MABR technology offering - SUBRE. We are excited about the value proposition of SUBRE, which we anticipate will enable us to expand the treatment capacity of our existing infrastructure, extend the design period of the plant, enhance energy efficiency and reduce our treatment costs."
"We are excited to collaborate with Mayanot Ha-Amakim on this project," said Henry Charrabe, Managing Director and CEO of Fluence. "We estimate that Europe alone potentially constitutes a nearly US$2 billion market opportunity for SUBRE, with even larger market potential in the USA and China, as regulations regarding total nitrogen content in treated effluent are becoming much stricter. We are already in discussion with some of our China partners regarding SUBRE deployments in China. Therefore, we can leverage our existing MABR strategic partnerships to accelerate growth, expand our product range in China and other global markets and strengthen our position as a provider of multi-faceted water treatment solutions. The launch of SUBRE demonstrates Fluence's ongoing innovation, which will continue to improve its positioning and maintain its leadership in markets it is addressing."
SUBRE Technology
Fluence's Chief Technology Officer Ronen Shechter and his team have developed SUBRE as Fluence's "next-generation" MABR technology designed for larger, centralized traditional treatment plants. SUBRE opens up a parallel wastewater treatment market in larger scale and existing municipal wastewater treatment facilities. Today, plants often use methanol to meet tighter nitrogen discharge rules. Methanol is hazardous, toxic, and flammable, potentially making site permitting complex and lengthy. It also presents an additional cost to plant operation. SUBRE avoids all of these barriers while meeting tighter discharge requirements and enhancing plant capacity. Fluence's product development team and production team will focus on the SUBRE production. SUBRE can also be produced at the Company's manufacturing facilities in Changzhou, China.
The Company is continuing to further refine the SUBRE product offering and enhance its channel-tomarket strategies. This new technology is expected to be commercially available to the broader market by the end of second quarter of 2018.
Fluence's China Management team has rapidly established an excellent network of strategic partnerships across China, with geographic coverage of over 70% of China. Many of these partners provide solutions for both centralized and rural, decentralized plants. In addition to its Five-Year Plan to service rural communities, the Chinese government is also prioritizing infrastructure upgrades in cities and large townships, which are anticipated to bring new opportunities for Fluence's SUBRE in China.
To view figures, please visit:
http://abnnewswire.net/lnk/RNGZCAV5
About Fluence Corporation Ltd
Fluence Corporation (ASX:FLC) (OTCMKTS:EMFGF) is a leader in the decentralized water, wastewater and reuse treatment markets, with its Smart Products Solutions, including Aspiral, NIROBOX, NIROFLEX and SUBRE. Fluence offers an integrated range of services across the complete water cycle, from early stage evaluation, through design and delivery to ongoing support and optimization of water related assets, as well as Build Own Operate Transfer (BOOT) and other recurring revenue solutions. With established operations in North America, South America, the Middle East, Europe and China, Fluence has experience operating in over 70 countries worldwide and enables businesses and communities worldwide to maximize their water resources.
Further information can be found at https://www.fluencecorp.com/
| ||
|